Impact of Dapagliflozin on Left ventricular hemodynamics and Exercise-induced Pulmonary hypertension evaluated by echocardiography in patients with type 2 diabetes; an open-label prospective randomized controlled trial

Trial Profile

Impact of Dapagliflozin on Left ventricular hemodynamics and Exercise-induced Pulmonary hypertension evaluated by echocardiography in patients with type 2 diabetes; an open-label prospective randomized controlled trial

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 14 Nov 2016

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Hypertension in diabetes; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms IDOL-EPOC
  • Most Recent Events

    • 11 Nov 2016 Status changed from not yet recruiting to recruiting.
    • 12 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top